The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Nicholas J. Wald

Wolfson Institute of Preventive Medicine

Barts and the London School of Medicine and Dentistry

Queen Mary University of London

Charterhouse Square


Name/email consistency: high



  • Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square. 2003 - 2012


  1. Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers. Wald, N.J., Bestwick, J.P., George, L.M., Wu, T., Morris, J.K. J. Med. Screen (2012) [Pubmed]
  2. Antenatal screening for Down's syndrome using the Integrated test at two London hospitals. Wald, N.J., Huttly, W.J., Murphy, K.W., Ali, K., Bestwick, J.P., Rodeck, C.H. J. Med. Screen (2009) [Pubmed]
  3. Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis. Wald, N.J., Morris, J.K., Walker, K., Simpson, J.M. Prenat. Diagn. (2008) [Pubmed]
  4. Should folic acid fortification be mandatory? Yes. Wald, N.J., Oakley, G.P. BMJ (2007) [Pubmed]
  5. Validation plots in antenatal screening for Down's syndrome. Wald, N.J., Bestwick, J.P., Huttly, W.J., Morris, J.K., George, L.M. J. Med. Screen (2006) [Pubmed]
  6. Sequential and contingent prenatal screening for Down syndrome. Wald, N.J., Rudnicka, A.R., Bestwick, J.P. Prenat. Diagn. (2006) [Pubmed]
  7. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy. Wald, N.J., Barnes, I.M., Birger, R., Huttly, W. Prenat. Diagn. (2006) [Pubmed]
  8. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers. Wald, N.J., Morris, J.K., Ibison, J., Wu, T., George, L.M. Prenat. Diagn. (2006) [Pubmed]
  9. Cross-trimester marker ratios in prenatal screening for Down syndrome. Wald, N.J., Bestwick, J.P., Morris, J.K. Prenat. Diagn. (2006) [Pubmed]
  10. SURUSS in perspective. Wald, N.J., Rodeck, C., Hackshaw, A.K., Rudnicka, A. Semin. Perinatol. (2005) [Pubmed]
  11. Prenatal screening for Down syndrome and neural tube defects in twin pregnancies. Wald, N.J., Rish, S. Prenat. Diagn. (2005) [Pubmed]
  12. The efficacy of combining several risk factors as a screening test. Wald, N.J., Morris, J.K., Rish, S. J. Med. Screen (2005) [Pubmed]
  13. Prenatal screening for Down syndrome: the problem of recurrent false-positives. Wald, N.J., Huttly, W.J., Rudnicka, A.R. Prenat. Diagn. (2004) [Pubmed]
  14. Antenatal screening for Down's syndrome with the quadruple test. Wald, N.J., Huttly, W.J., Hackshaw, A.K. Lancet (2003) [Pubmed]
  15. A new approach to antenatal screening for Fragile X syndrome. Wald, N.J., Morris, J.K. Prenat. Diagn. (2003) [Pubmed]
  16. Cystic fibrosis: selecting the prenatal screening strategy of choice. Wald, N.J., Morris, J.K., Rodeck, C.H., Haddow, J.E., Palomaki, G.E. Prenat. Diagn. (2003) [Pubmed]
  17. A strategy to reduce cardiovascular disease by more than 80%. Wald, N.J., Law, M.R. BMJ (2003) [Pubmed]
  18. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Wald, N.J., Rish, S., Hackshaw, A.K. Prenat. Diagn. (2003) [Pubmed]
  19. Teleoanalysis: combining data from different types of study. Wald, N.J., Morris, J.K. BMJ (2003) [Pubmed]
WikiGenes - Universities